Credit: MotivateBootCamp. In recent years, the popularity of weight-loss drugs like Ozempic and Wegovy has soared so dramatically that they’ve inspired new vocabulary, spurred global shortages, and prompted moral debates. Prescription growth hit 13% in just three months, with 2 million Americans now using the drug. Marketed as “miracle drugs,” these medications, part of a class called GLP-1 receptor agonists, …
Read More »